probenecid has been researched along with XYY Karyotype in 1 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
XYY Karyotype: Abnormal genetic constitution in males characterized by an extra Y chromosome.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bioulac, B | 1 |
| Benezech, M | 1 |
| Renaud, B | 1 |
| Noel, B | 1 |
| Roche, D | 1 |
1 other study available for probenecid and XYY Karyotype
| Article | Year |
|---|---|
Serotoninergic dysfunction in the 47, XYY syndrome.
Topics: 5-Hydroxytryptophan; Adult; Dopamine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Pro | 1980 |